retatrutide triple hormone receptor agonist metabolic 𧬠R3TA is a next-generation peptide being studied for its unique triple- approach to health. Unlike traditional GLP-1 therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, GIP Retatrutide Triple Hormone Receptor Agonist:
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 30 - Aug 4























